D
Cardiff Oncology, Inc. CRDF
$4.00 $0.051.27%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -8.48% 1.23%
Total Other Revenue -- --
Total Revenue -8.48% 1.23%
Cost of Revenue 0.75% 1.55%
Gross Profit -0.91% -1.55%
SG&A Expenses -3.68% -2.77%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -0.34% 0.46%
Operating Income 0.23% -0.45%
Income Before Tax 0.57% -0.65%
Income Tax Expenses -- --
Earnings from Continuing Operations 0.57% -0.65%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 0.57% -0.65%
EBIT 0.23% -0.45%
EBITDA 0.19% -0.48%
EPS Basic 14.07% 3.73%
Normalized Basic EPS 14.04% 3.71%
EPS Diluted 14.07% 3.73%
Normalized Diluted EPS 14.04% 3.71%
Average Basic Shares Outstanding 15.69% 4.55%
Average Diluted Shares Outstanding 15.69% 4.55%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings